Skip to main content

Development of Impaired Lung Function: Natural History and Risk Factors

  • Chapter
Book cover Chronic Obstructive Pulmonary Disease

Abstract

The definition of COPD adopted in this chapter is that proposed by Burrows [1]:

‘A chronic, slowly progressive airway obstruction disorder resulting from some combination of pulmonary emphysema and irreversible reduction in the calibre of small airways of the lung’.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Burrows, B. (1985). Course and prognosis in advanced disease, in Chronic Obstructive Pulmonary Disease, (ed. T.L. Petty), Marcel Dekker Inc., New York, pp. 31–42.

    Google Scholar 

  2. Fletcher, C. and Peto, R. (1977). The natural history of chronic airflow obstruction. Br. Med. J., i, 1645–8.

    Article  Google Scholar 

  3. Fletcher, C.M., Peto, R., Tinker, C.M. and Speizer, F.E. (1976). The Natural History of Chronic Bronchitis and Emphysema. Oxford University Press, Oxford.

    Google Scholar 

  4. Peto, R., Speizer, F.E., Cochrane, A.L. et al. (1983). The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Am. Rev. Respir. Dis., 128, 491–500.

    PubMed  CAS  Google Scholar 

  5. Lange, P., Nyboe, J., Appleyard, M. et al. (1990). The relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax, 45, 579–85.

    Article  PubMed  CAS  Google Scholar 

  6. Speizer, F.E., Fay, M.E., Dockery, D.W. and Ferris, B.G. Jr (1989). Chronic obstructive pulmonary disease mortality in six U.S. Cities. Am. Rev. Respir. Dis., 140, S49–S55.

    Article  PubMed  CAS  Google Scholar 

  7. Burrows, B., Knudson, R.J., Camilli, A.E. et al. (1987). The ‘Horse-Racing effect’ and predicting decline in forced expiratory volume in one second from screening spirometry. Am. Rev. Respir. Dis., 135, 788–93.

    PubMed  CAS  Google Scholar 

  8. Burrows, B. (1991). Predictors of loss of lung function and mortality in obstructive lung diseases. Eur. Respir. Rev., 1, 340–5.

    Google Scholar 

  9. Tweeddale, P.M., Merchant, S., Leslie, M. et al. (1984). Short term variability in FEV1: relation to pretest activity, levels of FEV1, and smoking habits. Thorax, 39, 928–32.

    Article  PubMed  CAS  Google Scholar 

  10. Buist, A.S., Vollmer, W.M., Johnson, L.R. and McCamant, L.E. (1988). Does the single-breath N2 test identify the smoker who will develop chronic airflow limitation? Am. Rev. Respir. Dis., 137, 293–310.

    Article  PubMed  CAS  Google Scholar 

  11. Watson, A., Joyce, H., Hopper, L. and Pride, N.B. (1993). Influence of smoking habits on change in carbon monoxide transfer factor over 10 years in middle-aged men. Thorax, 48, 119–24.

    Article  PubMed  CAS  Google Scholar 

  12. McLean, A., Warren, P.M., Gillooly, M. et al. (1992). Microscopic and macroscopic measurement of emphysema: relation to carbon monoxide gas transfer. Thorax, 47, 144–9.

    Article  PubMed  CAS  Google Scholar 

  13. Gould, G.A., Macnee, W., Mclean, A. et al. (1988). CT measurements of lung density in life can quantitate distal airspace enlargement — an essential defining feature of human emphysema. Am. Rev. Respir. Dis., 137, 380–92.

    Article  PubMed  CAS  Google Scholar 

  14. Knudson, R.J., Kaltenborn, W.T. and Burrows, B. (1989) The effects of cigarette smoking and smoking cessation on the carbon monoxide diffusing capacity of the lung in asymptomatic subjects. Am. Rev. Respir. Dis., 140, 645–51.

    Article  PubMed  CAS  Google Scholar 

  15. Petrik Pereira R., Hunter, D. and Pride, N.B. (1981). Use of lung pressure-volume curves and helium-sulphur hexafluoride washout to detect emphysema in subjects with mild airflow obstruction. Thorax, 36, 29–37.

    Article  Google Scholar 

  16. Corbin, R.P., Loveland, M., Martin, R.R. and Macklem, P.T. (1979) A four-year follow-up study of lung mechanics in smokers. Am. Rev. Respir. Dis., 120, 293–304.

    PubMed  CAS  Google Scholar 

  17. Anthonisen, N.R. (1989) Prognosis in chronic obstructive pulmonary disease: results from multicenter clinical trials. Am. Rev. Respir. Dis., 140, S95–S99.

    Article  PubMed  CAS  Google Scholar 

  18. Weitzenblum, E., Sautegeau, A., Ehrhart, M. et al. (1984). Long-term course of pulmonary arterial pressure in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis., 130, 993–8.

    PubMed  CAS  Google Scholar 

  19. Larsson, C. (1978) Natural history and life expectancy in severe alpha1-antitrypsin deficiency, PiZ. Acta Med. Scand., 204, 345–51.

    Article  PubMed  CAS  Google Scholar 

  20. Tager, I.B., Segal, M.R., Speizer, F.E. and Weiss, S.T. (1988). The natural history of forced expiratory volumes. Effect of cigarette smoking and respiratory symptoms. Am. Rev. Respir. Dis., 138, 837–49.

    Article  PubMed  CAS  Google Scholar 

  21. Doll, R. and Peto, R. (1976) Mortality in relation to smoking: 20 years’ observation on male British doctors. Br. Med. J., 2, 1525–36.

    Article  PubMed  CAS  Google Scholar 

  22. Higenbottam, J., Shipley, M.J., Clark, T.J.H. and Rose, G. (1980) Lung function and symptoms of cigarette smokers related to tar yield and number of cigarettes smoked, Lancet, i, 409–12.

    Article  Google Scholar 

  23. Schenker, M.B., Samet, J.M. and Speizer, F.E. (1982) Effect of cigarette tar content and smoking habits on respiratory symptoms in women. Am. Rev. Respir. Dis., 125, 684–90.

    PubMed  CAS  Google Scholar 

  24. US Department of Health and Human Services (1981). Public Health Service, Office on Smoking and Health. The health consequences of smoking — the changing cigarette: a report of the Surgeon General.

    Google Scholar 

  25. Royal College of Physicians of London (1983) Health or Smoking? Pitman, London.

    Google Scholar 

  26. Krzyanowski, M., Sherrill, D.L., Paoletti, P. and Lebowitz, M.D. (1991) Relationship of respiratory symptoms and pulmonary function to tar, nicotine, and carbon monoxide yield of cigarettes. Am. Rev. Respir. Dis., 143, 306–11.

    Article  Google Scholar 

  27. Lee, P.N. and Garfinkel, L. (1981). Mortality and type of cigarette smoked. J. Epidemiol. Community Health, 35, 16–22.

    Article  PubMed  CAS  Google Scholar 

  28. Withey, C.H., Papacosta, O., Swan, A.V. et al. (1992) Respiratory effects of lowering tar and nicotine levels of cigarettes smoked by young male middle tar smokers. II: Results of a randomised controlled trial. J. Epidemiol. Comm. Health, 46, 281–5.

    Article  CAS  Google Scholar 

  29. Becklake, M.R. (1989). Occupational exposures: evidence for a causal association with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis., 140, S85–S89.

    Article  PubMed  CAS  Google Scholar 

  30. Speizer, F.E. (1994) Environmental lung disease, in: Harrison’s Principles of Internal Medicine (eds J.D. Wilson et al.), 13th edn, McGraw-Hill, New York, pp. 1176–83.

    Google Scholar 

  31. Korn, R.J., Dockery, D.W., Speizer, F.E. et al. (1987). Occupational exposures and chronic respiratory symptoms. Am. Rev. Respir. Dis., 136, 296–304.

    Article  Google Scholar 

  32. Xu, X., Christiani, D.C., Dockery, D.W. and Wang, L. (1992) Exposure-response relationships between occupational exposures and chronic respiratory illness: a community-based study. Am. Rev. Respir. Dis., 146, 413–8.

    Article  PubMed  CAS  Google Scholar 

  33. Love, R.G. and Miller, B.G. (1982). Longitudinal study of lung function in coal-miners. Thorax, 37, 193–7.

    Article  PubMed  CAS  Google Scholar 

  34. Marine, W.M., Gurr, D. and Jacobsen, M. (1988) Clinically important respiratory effects of dust exposure and smoking in British coal miners. Am. Rev. Respir. Dis., 137, 106–12.

    Article  PubMed  CAS  Google Scholar 

  35. Oxman, A.D., Muir, D.C., Shannon, H.S. et al. (1993). Occupational dust exposure and chronic obstructive pulmonary disease. A systematic overview of the evidence. Am. Rev. Respir. Dis., 148, 38–48.

    Article  PubMed  CAS  Google Scholar 

  36. Zuskin, E., Ivankovic, D., Schachter, E.N. and Witek, T.J. Jr (1991) A ten-year follow-up study of cotton textile workers. Am. Rev. Respir. Dis., 143, 301–5.

    Article  PubMed  CAS  Google Scholar 

  37. Glindmeyer, H.W., Lefante, J.J., Jones, R.N. et al. (1991) Exposure-related declines in the lung function of cotton textile workers. Am. Rev. Respir. Dis., 144, 675–83.

    Article  PubMed  CAS  Google Scholar 

  38. Enarson, D.A., Vedal, S. and Chan-Yeung, M. (1985) Rapid decline in FEV1 in grain handlers. Am. Rev. Respir. Dis., 132, 814–7.

    PubMed  CAS  Google Scholar 

  39. Davison, A.G., Fayers, P.M., Newman-Taylor, A.J. et al. (1988) Cadmium fume inhalation and emphysema. Lancet, i, 663–7.

    Article  Google Scholar 

  40. Hutchison, D.C.S. (1988) Natural history of alpha-1-protease inhibitor deficiency. Am. J. Med., 84(Suppl. 6A), 3–12.

    PubMed  CAS  Google Scholar 

  41. Bartmann, K., Fooke-Achterrath, M., Koch, G. et al. (1985) Heterozygosity in the Pi-system as a pathogenic cofactor in chronic obstructive pulmonary disease (COPD). Eur. J. Respir. Dis., 66, 284–96.

    PubMed  CAS  Google Scholar 

  42. Lieberman, J., Winter, B. and Sastre, A. (1986) Alpha1-antitrypsin Pi-types in 965 COPD patients. Chest, 89, 370–3.

    Article  PubMed  CAS  Google Scholar 

  43. Hutchison, D.C.S., Tobin, M.J. and Cook, P.J.L. (1983). Alpha1-antitrypsin deficiency: clinical and physiological features in heterozygotes of Pi type SZ. A survey by the British Thoracic Association. Br. J. Dis. Chest, 77, 28–34.

    Article  PubMed  CAS  Google Scholar 

  44. Shigeoka, J.W., Hall, W.J., Hyde, R.W. et al. (1976) The prevalence of alpha1-antitrypsin heterozygotes (PiMZ) in patients with obstructive pulmonary disease. Am. Rev. Respir. Dis., 114, 1077–84.

    PubMed  CAS  Google Scholar 

  45. Morse, J.O., Lebowitz, M.D., Knudson, R.J. and Burrows, B. (1977) Relation of protease inhibitor phenotypes to obstructive lung diseases in a community. N. Engl. J. Med., 296, 1190–4.

    Article  PubMed  CAS  Google Scholar 

  46. Tattersall, S.F., Petrik Pereira, R., Hunter, D. et al. (1979). Lung distensibility and airway function in intermediate alpha1-antitrypsin deficiency (Pi MZ). Thorax, 34, 637–46.

    Article  PubMed  CAS  Google Scholar 

  47. Bruce, R.M., Cohen, B.H., Diamond, E.L. et al. (1984) Collaborative study to assess risk of lung disease in Pi MZ phenotype subjects. Am. Rev. Respir. Dis., 130, 386–90.

    PubMed  CAS  Google Scholar 

  48. Eriksson, S., Lindell, S-E. and Wiberg, R. (1985). Effects of smoking and intermediate alpha1-antitrypsin deficiency (PiMZ) on lung function. Eur. J. Respir. Dis., 67, 279–85.

    PubMed  CAS  Google Scholar 

  49. Silverman, E.K., Pierce, J.A., Province, M.A. et al. (1989). Variability of pulmonary function in alpha1-antitrypsin deficiency: clinical correlates. Ann. Intern. Med., 111, 982–91.

    Article  PubMed  CAS  Google Scholar 

  50. Janus, E.D., Phillips, N.T. and Carrell, R.W. (1985). Smoking, lung function and alpha1-antitrypsin deficiency. Lancet, 1, 152–4.

    Article  PubMed  CAS  Google Scholar 

  51. Buist, A.S., Burrows, B., Eriksson, S. et al. (1983). The natural history of air-flow obstruction in PiZ emphysema. Am. Rev. Respir. Dis., 127, S43–S45.

    PubMed  CAS  Google Scholar 

  52. Troyer, B.E., Silverman, E.K., Wade, M.A. and Campbell, E.J. (1994). α1-antitrypsin deficiency detected through blood donor screening: clinical features and natural history. Am. J. Resp. Crit. Care Med., 149, A1014.

    Google Scholar 

  53. Brumfitt, W., Willoughby, M.L.N. and Bromley, L.L. (1957) An evaluation of sputum examination in chronic bronchitis. Lancet, ii, 1306–9.

    Article  Google Scholar 

  54. Medical Research Council (1965). Definition and classification of chronic bronchitis for clinical and epidemiological purposes. Lancet, i, 775–9.

    Google Scholar 

  55. Medical Research Council (1966) Value of chemoprophylaxis and chemotherapy in chronic bronchitis. Br. Med. J., 1, 1317–22.

    Article  Google Scholar 

  56. Johnston, R.N., McNeill, R.S., Smith, D.H. et al. (1969) Five-year winter prophylaxis for chronic bronchitis. Br. Med. J., 4, 265–9.

    Article  PubMed  CAS  Google Scholar 

  57. Johnston, R.N., McNeill, R.S., Smith, D.H. et al. (1976) Chronic bronchitis — measurements and observations over 10 years. Thorax, 31, 25–9.

    Article  PubMed  CAS  Google Scholar 

  58. Clément, J. and Van de Woestijne, K.P. (1982) Rapidly decreasing forced expiratory volume in one second or vital capacity and development of chronic airflow obstruction. Am. Rev. Respir. Dis., 125, 553–8.

    PubMed  Google Scholar 

  59. Higgins, M.W., Keller, J.B., Becker, M. et al. (1982) An index of risk for obstructive airways disease. Am. Rev. Respir. Dis., 125, 144–51.

    PubMed  CAS  Google Scholar 

  60. Annesi, I. and Kauffman, F. (1986) Is respiratory mucus hypersecretion really an innocent disorder? Am. Rev. Respir. Dis., 134, 688–93.

    PubMed  CAS  Google Scholar 

  61. Ebi-Kryston, K.L. (1988). Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease and all causes in the Whitehall study. J. Clin. Epidemiol., 41, 251–60.

    Article  PubMed  CAS  Google Scholar 

  62. Kryzyzanowski, M. and Wysocki, M. (1986). The relation of thirteen-year mortality to ventilatory impairment and other respiratory symptoms. Int. J. Epidemiol., 15, 56–64.

    Article  Google Scholar 

  63. Kanner, R.S., Renzetti, A.D. Jr, Klauber, M.R. et al. (1979). Variables associated with changes in spirometry in patients with obstructive lung diseases. Am. J. Med., 67, 44–50.

    Article  PubMed  CAS  Google Scholar 

  64. Wang, E.E.L., Prober, C.G., Mansion, B. et al. (1984). Association of respiratory viral infection with pulmonary deterioration in patients with cystic fibrosis. N. Engl. J. Med., 311, 1653–8.

    Article  PubMed  CAS  Google Scholar 

  65. Björkander, J., Bake, B. and Hansion, L.A. (1984). Primary hypogammaglobulinaemia: impaired lung function and body growth with delayed diagnosis and inadequate treatment. Eur. J. Respir. Dis., 65, 529–36.

    PubMed  Google Scholar 

  66. Björkander, J., Bake, B., Oxelius, V.A. et al. (1985). Impaired lung function in patients with IgA deficiency and low levels of IgG2 or IgG3. N. Engl J. Med., 313, 720–4.

    Article  PubMed  Google Scholar 

  67. Samet, J.M., Tager, I.B. and Speizer, F.E. (1983) The relationship between respiratory illness in childhood and chronic air-flow obstruction in adulthood. Am. Rev. Respir. Dis., 127, 508–23.

    PubMed  CAS  Google Scholar 

  68. Orie, N.G.M., Sluiter, H.J., De Vries, K. et al. (1961). The host factor in bronchitis, in: Bronchitis, an International Symposium, 27–29 April 1960, University of Grönigen. Royal Van Gorcum, Assen, pp. 43–49.

    Google Scholar 

  69. Pride, N.B., Taylor, R.G., Lim, T.K. et al. (1987). Bronchial hyperresponsiveness as a risk factor for progressive airflow obstruction in smokers. Bull. Eur. Physio-Pathol. Respir., 23, 369–75.

    CAS  Google Scholar 

  70. O’Connor, G.T., Sparrow, D. and Weiss, S.T. (1989) The role of allergy and nonspecific airway hyperresponsiveness in the pathogenesis of chronic obstructive pulmonary disease. Am. Rev. Respir. Dis., 140, 225–52.

    Article  PubMed  Google Scholar 

  71. Burrows, B., Halonen, M., Barbee, R.A. and Lebowitz, M. (1981) The relationship of serum immunoglobulin E to cigarette smoking. Am. Rev. Respir. Dis., 124, 523–5.

    PubMed  CAS  Google Scholar 

  72. Warren, C.P., Holford-Strevens, V., Wong, C. and Manfreda, J. (1982). The relationship between smoking and total immunoglobulin E levels. J. Allergy Clin. Immunol., 69, 370–5.

    Article  PubMed  CAS  Google Scholar 

  73. Taylor, R.G., Gross, E. Joyce, H. et al. (1985). Smoking, allergy and the differential white blood cell count. Thorax, 40, 17–22.

    Article  PubMed  CAS  Google Scholar 

  74. Burney, P.G.J., Britton, J.R., Chinn, S. et al. (1987) Descriptive epidemiology of bronchial reactivity in an adult population: results from a community study. Thorax, 42, 38–44.

    Article  PubMed  CAS  Google Scholar 

  75. Taylor, R.G., Joyce, H., Gross, E. et al. (1985). Bronchial reactivity to inhaled histamine and annual rate of decline in FEV1 in male smokers and ex-smokers. Thorax, 40, 9–16.

    Article  PubMed  CAS  Google Scholar 

  76. Tashkin, D.P., Altose, M.D., Bleecker, E. et al., (1992) The Lung Health Study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. Am. Rev. Respir. Dis., 145, 301–10.

    Article  PubMed  CAS  Google Scholar 

  77. Cockcroft, D.W., Killian, D.N., Mellon, J.A. and Hargreave, F.E. (1977). Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin. Allergy, 7, 235–43.

    Article  PubMed  CAS  Google Scholar 

  78. Woolcock, A.J., Salome, C.M. and Yan, K. (1984). The shape of the dose-response curve to histamine in asthmatic and normal subjects. Am. Rev. Respir. Dis., 130, 171–5.

    Google Scholar 

  79. Sterk, P.J., Daniel, E.E., Zamel, N. and Hargreave, F.E. (1985) Limited bronchoconstriction to methacholine using partial flow-volume curves in nonasthmatic subjects. Am. Rev. Respir. Dis., 132, 272–7.

    PubMed  CAS  Google Scholar 

  80. Du Toit, J.I., Woolcock, A.J., Salome, C.M. et al. (1986). Characteristics of bronchial hyper-responsiveness in smokers with chronic airflow limitation. Am. Rev. Respir. Dis., 134, 498–501.

    PubMed  Google Scholar 

  81. Higgins, B.G., Britton, J.R., Chinn, S. et al. (1988) Comparison of histamine and methacholine for use in bronchial challenge tests in community studies. Thorax, 43, 605–10.

    Article  PubMed  CAS  Google Scholar 

  82. Ramsdale, E.H., Morris, M.M. and Hargreave, F.E. (1986). Interpretation of the variability of peak flow rates in chronic bronchitis. Thorax, 41, 771–6.

    Article  PubMed  CAS  Google Scholar 

  83. James, A.L., Paré, P.D. and Hogg, J.C. (1989). The mechanics of airway narrowing in asthma. Am. Rev. Respir. Dis., 139, 242–6.

    Article  PubMed  CAS  Google Scholar 

  84. Kuwano, K., Bosken, C.H., Paré, P.D. et al. (1993). Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis., 148, 1220–5.

    Article  PubMed  CAS  Google Scholar 

  85. Phillips, G.D., Rafferty, P., Beasley, R. and Holgate, S.T. (1987) Effect of oral terfenadine on the bronchoconstrictor response to inhaled histamine and adenosine 5′-monophosphate in non-atopic asthma. Thorax, 42, 939–45.

    Article  PubMed  CAS  Google Scholar 

  86. Tattersfield, A.E. (1987). Effect of beta-agonists and anticholinergic drugs on bronchial reactivity. Am. Rev. Respir. Dis., 136, S64–S68.

    Article  PubMed  CAS  Google Scholar 

  87. Lim, T.K., Turner, N.C., Watson, A. et al. (1990). Effects of nonsteroidal anti-inflammatory drugs on the bronchial hyperresponsiveness of middle-aged male smokers. Eur. Respir. J., 3, 872–9.

    PubMed  CAS  Google Scholar 

  88. Cheung, D., Merkenhof, W.M., Schot, R. et al. (1993) Relationship between indices of parenchymal destruction and maximal airway narrowing in vivo in humans with α1-antitrypsin deficiency. Am. Rev. Respir. Dis., 147, A834.

    Google Scholar 

  89. Bloom, J.W., Halonen, M., Dunn, A.M. et al. (1986). Pneumococcus-specific immunoglobin E in cigarette smokers. Clin. Allergy, 16, 25–32.

    Article  PubMed  CAS  Google Scholar 

  90. Zetterstrom, O., Osterman, K., Machado, L. and Johansson, S.G.O. (1981) Another smoking hazard: raised serum IgE concentration and increased risk of occupational allergy. Br. Med. J., 283, 1215–7.

    Article  CAS  Google Scholar 

  91. Venables, K.M., Topping, M.D., Howe, W. et al. (1985). Interaction of smoking and atopy in producing specific IgE antibody against a hapten protein conjugate. Br. Med. J, 290, 201–4.

    Article  CAS  Google Scholar 

  92. O’Connor, G.T., Sparrow, D., Segal, M.R. and Weiss, S.T. (1989) Smoking, atopy, and methacholine airway responsiveness among middle-aged and elderly men. Am. Rev. Respir. Dis., 140, 1520–6.

    Article  PubMed  Google Scholar 

  93. Frette, C., Annesi, I., Korobaeff, M. et al. (1991) Blood eosinophilia and FEV1. Am. Rev. Respir. Dis., 143, 987–92.

    Article  PubMed  CAS  Google Scholar 

  94. Burrows, B., Hasan, F.M., Barbee, R.A. et al. (1980) Epidemiologic observations on eosinophilia and its relation to respiratory disorders. Am. Rev. Respir. Dis., 122, 709–19.

    PubMed  CAS  Google Scholar 

  95. Burrows, B., Knudson, R.J., Clinc, M.G. and Lebowitz, M.D. (1988) A re-examination of risk factors for ventilatory impairment. Am. Rev. Respir. Dis., 138, 829–36.

    Article  PubMed  CAS  Google Scholar 

  96. Higenbottam, T.W., Feyerabend, C. and Clark, T.J.H. (1980). Cigarette smoking in asthma. Br. J. Dis. Chest, 74, 279–84.

    Article  PubMed  CAS  Google Scholar 

  97. Vesterinen, E., Kaprio, J. and Koskenvuo, M. (1988) Prospective study of asthma in relation to smoking habits among 14729 adults. Thorax, 43, 534–9.

    Article  PubMed  CAS  Google Scholar 

  98. Hillerdahl, G. and Rylander, R. (1984) Asthma and cessation of smoking. Clin. Allergy, 14, 45–7.

    Article  PubMed  CAS  Google Scholar 

  99. Burrows, B., Bloom, J.W., Traver, G.A. and Cline, M.G. (1987) The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N. Engl. J. Med., 317, 1309–14.

    Article  PubMed  CAS  Google Scholar 

  100. Tager, I. and Speizer, F.E. (1976) Risk estimates for chronic smokers — a study of male-female differences. Am. Rev. Respir. Dis., 113, 619–25.

    PubMed  CAS  Google Scholar 

  101. Dompeling, E., Van Schayck, C.P, Van Grunsven, P.M. et al. (1993). Slowing the deterioration of asthma and COPD observed during bronchodilator therapy by adding inhaled corticosteroids. Am. Intern. Med., 118, 770–8.

    Article  CAS  Google Scholar 

  102. Camilli, A.E., Burrows, B., Knudson, R.J. et al. (1987) Longitudinal changes in forced expiratory volume in one second in adults. Effects of smoking and smoking cessation. Am. Rev. Respir. Dis., 135, 794–9.

    PubMed  CAS  Google Scholar 

  103. Cherniack, R.M. and McCarthy, D.S. (1979). Reversibility of abnormalities of pulmonary function, in The Lung in the Transition Between Health and Disease, (eds P.T. Macklem and S. Permutt), Vol. 12 Dekker, New York, pp. 329–42.

    Google Scholar 

  104. U.S. Department of Health and Human Services (1990) The health benefits of smoking cessation — a report of the Surgeon General. Centers for Disease Control, Office on Smoking and Health, Rockville, Maryland. DHHS Publication No. CDC 90-8416.

    Google Scholar 

  105. Burrows, B., Knudson, R.J., Cline, M.C. and Lebowitz, M.D. (1977). Quantitative relationships between cigarette smoking and ventilatory function. Am. Rev. Respir. Dis., 115, 195–205.

    PubMed  CAS  Google Scholar 

  106. Beck, G.J., Doyle, C.A. and Schachter, E.N. (1981) Smoking and lung function. Am. Rev. Respir. Dis., 123, 149–55.

    PubMed  CAS  Google Scholar 

  107. Dockery, D.W., Speizer, F.E., Ferris, B.G. Jr et al. (1988). Cumulative and reversible effects of lifetime smoking on simple tests of lung function in adults. Am. Rev. Respir. Dis., 137, 286–92.

    Article  PubMed  CAS  Google Scholar 

  108. IPPB Trial Group (1983) Intermittent positive pressure breathing therapy of chronic obstructive pulmonary disease. Ann. Intern. Med., 99, 612–20.

    Article  Google Scholar 

  109. Ashley, F., Kannel, W.B., Soolie, P. and Masson, R. (1975). Pulmonary function: relation to aging, cigarette habit, and mortality. The Framingham Study. Ann. Intern. Med., 82, 739–45.

    Article  PubMed  CAS  Google Scholar 

  110. Cook, D.G., and Shaper, A.G. (1988). Breathlessness, lung function and risk of a heart attack. Eur. Heart J., 9, 1215–22.

    PubMed  CAS  Google Scholar 

  111. Tockman, M.S., Anthonisen, N.R., Wright, E.C. and Donithan, M.G. (1987) IPPB Trial Group, Johns Hopkins Lung Project. Airways obstruction and the risk for lung cancer. Ann. Intern. Med., 106, 512–8.

    Article  PubMed  CAS  Google Scholar 

  112. Burrows, B. (1989) The course and prognosis of different types of chronic airflow limitation in a general population sample from Arizona: comparison with the Chicago ‘COPD’ series. Am. Rev. Respir. Dis., 140, S92–S94.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Pride, N.B., Burrows, B. (1995). Development of Impaired Lung Function: Natural History and Risk Factors. In: Calverley, P.M.A., Pride, N.B. (eds) Chronic Obstructive Pulmonary Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-4525-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-4525-9_5

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-412-46450-8

  • Online ISBN: 978-1-4899-4525-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics